Form 4: LQDT Executive Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Liquidity Services EVP, Chief Commercial Officer John Daunt sold 2,600 shares of common stock at $31.67 per share as part of a pre-arranged 10b5-1 trading plan.

Summary

  • John Daunt, EVP, Chief Commercial Officer of Liquidity Services, Inc. (LQDT), reported a sale of common stock.
  • The transaction involved the disposition of 2,600 shares of common stock.
  • The shares were sold at a price of $31.67 per share.
  • The sale was executed on March 11, 2026.
  • Following this transaction, John Daunt beneficially owns 45,452 shares indirectly through The Daunt Family Trust.
  • The transaction was conducted pursuant to a Rule 10b5-1(c) trading plan, indicating it was pre-scheduled.
  • The filing also details various Restricted Stock Unit (RSU) and Stock Option grants held by Mr. Daunt, with various vesting schedules and expiration dates extending to 2035.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale reduces direct ownership, its execution under a 10b5-1 plan mitigates concerns about negative sentiment, and the executive retains substantial equity holdings.

Positives

  • The sale was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled transaction rather than a reaction to new, non-public information.
  • Mr. Daunt retains significant beneficial ownership of 45,452 shares through The Daunt Family Trust, plus a substantial number of derivative securities (RSUs and stock options).

Negatives

  • An insider sale, even if pre-planned, can sometimes be perceived negatively by the market as it reduces direct ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales under a Rule 10b5-1 plan are common practice for executives to diversify holdings and manage liquidity without signaling a change in their outlook on the company's prospects. This type of transaction is generally viewed as less impactful than an unplanned open-market sale.

Stakeholder Impact

  • Shareholders: May observe a slight decrease in insider ownership, but the 10b5-1 plan context suggests no immediate negative implications for company performance.

Next Steps

  • Additional 1/48th of certain stock option grants will vest each month for thirty-six months following January 1, 2023, January 1, 2024, and January 1, 2025.
  • Additional 1/48th of certain stock option grants will vest each month for thirty-six months following January 1, 2026, and January 1, 2027.
  • Remaining portions of various restricted stock unit grants will vest on January 1, 2027, January 1, 2028, January 1, 2029, and January 1, 2030, based on specific schedules and financial milestones.
  • Certain stock options will become exercisable based on the Issuer's achievement of financial milestones.

Key Dates

DateDescription
01/01/202312/48th of a stock option grant vested, with an additional 1/48th vesting each month for thirty-six months.
01/01/202412/48th of a stock option grant vested, with an additional 1/48th vesting each month for thirty-six months. Also, certain stock options became fully exercisable.
01/01/2024Twenty-five percent of a restricted stock unit grant vested, with subsequent vesting on January 1, 2025, January 1, 2026, and January 1, 2027.
01/01/202512/48th of a stock option grant vested, with an additional 1/48th vesting each month for thirty-six months.
01/01/2025Twenty-five percent of a restricted stock unit grant vested, with subsequent vesting on January 1, 2026, January 1, 2027, and January 1, 2028.
01/01/2026Twenty-five percent of a restricted stock unit grant vests, with subsequent vesting on January 1, 2027, January 1, 2028, and January 1, 2029.
01/01/202612/48th of a stock option grant will vest, with an additional 1/48th vesting each month for thirty-six months.
03/11/2026Date of common stock disposition by John Daunt.
03/13/2026Signature date of the reporting person (by power of attorney).
01/01/2027Twenty-five percent of a restricted stock unit grant vests, with subsequent vesting on January 1, 2028, January 1, 2029, and January 1, 2030.
01/01/202712/48th of a stock option grant will vest, with an additional 1/48th vesting each month for thirty-six months.
12/04/2028Expiration date for certain stock option grants.
01/01/2029Expiration date for certain restricted stock unit grants.
12/01/2030Expiration date for certain stock option grants.
01/01/2030Expiration date for certain restricted stock unit grants.
12/07/2031Expiration date for certain stock option grants.
12/23/2032Expiration date for certain stock option grants.
12/22/2033Expiration date for certain stock option grants.
10/30/2034Expiration date for certain stock option grants.
10/29/2035Expiration date for certain stock option grants.

Recommendation

hold

The insider sale, executed under a pre-arranged 10b5-1 plan, is a routine event for executive liquidity and diversification, not indicative of a change in company fundamentals or outlook. The executive retains significant equity, suggesting continued alignment with shareholder interests. Therefore, the filing itself does not warrant a change in investment posture.

Keywords

Liquidity Services, LQDT, Insider Trading, Form 4, Stock Sale, Executive Compensation, John Daunt, 10b5-1 Plan, Common Stock, Restricted Stock Units, Stock Options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.